Firefly Neuroscience Inc's Business Segments

Firefly Neuroscience, Inc. is an artificial intelligence company specializing in precision neuroscience through the application of AI and large-scale electrophysiological data to enhance clinical understanding of brain function. The company developed the Firefly Platform, which integrates hardware, software, and data infrastructure to capture standardized electroencephalographic (EEG) and event-related potential (ERP) assessments at the point of care. This data is processed by a proprietary analytics engine and delivered as structured reports to support clinical decision-making. Firefly's FDA 510(k)-cleared Evoke System, deployed in over 85 clinical sites in the United States as of December 31, 2025, enables clinicians to perform EEG and ERP assessments analyzed via a cloud-based platform. The system employs a 19-channel EEG electrode array and an integrated Heart Rate Variability sensor to capture multimodal brain and autonomic nervous system data. It records resting-state EEG and ERPs during cognitive tasks, assessing up to 20 cognitive functions per session. The standardized acquisition protocol ensures data comparability, contributing to the proprietary database and supporting future clinical assessments. Firefly Neuroscience aims to enhance brain health diagnostics by integrating electrophysiological data with behavioral assessments, providing population-level context, facilitating earlier detection of neurological diseases, and improving treatment selection through identification of electrophysiological subtypes.